Patrick Gizzi

Strasbourg, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Publisher Correction: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin.

Publisher Correction: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin.

Journal: Nature

Published: July 14, 2025

Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin.

Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin.

Journal: Nature

Published: October 09, 2023

Kinetic solubility: Experimental and machine-learning modeling perspectives.

Kinetic solubility: Experimental and machine-learning modeling perspectives.

Journal: Molecular informatics

Published: August 22, 2023

Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis.

Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 25, 2022

A Selective Neutraligand for CXCL12/SDF-1α With Beneficial Regulatory Functions in MRL/Lpr Lupus Prone Mice.

A Selective Neutraligand for CXCL12/SDF-1α With Beneficial Regulatory Functions in MRL/Lpr Lupus Prone Mice.

Journal: Frontiers in pharmacology

Published: August 02, 2021

Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.

Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: June 18, 2021

Identification of an N-acylated-DArg-Leu-NH2 Dipeptide as a Highly Selective Neuropeptide FF1 Receptor Antagonist That Potently Prevents Opioid-Induced Hyperalgesia.

Identification of an N-acylated-DArg-Leu-NH2 Dipeptide as a Highly Selective Neuropeptide FF1 Receptor Antagonist That Potently Prevents Opioid-Induced Hyperalgesia.

Journal: Journal of medicinal chemistry

Published: May 19, 2021

New contributions to the drug profile of TNFα inhibitor SPD304: Affinity, selectivity and ADMET considerations.

New contributions to the drug profile of TNFα inhibitor SPD304: Affinity, selectivity and ADMET considerations.

Journal: European journal of pharmacology

Published: March 13, 2021

Discovery, SAR study and ADME properties of methyl 4-amino-3-cyano-1-(2-benzyloxyphenyl)-1H-pyrazole-5-carboxylate as an HIV-1 replication inhibitor.

Discovery, SAR study and ADME properties of methyl 4-amino-3-cyano-1-(2-benzyloxyphenyl)-1H-pyrazole-5-carboxylate as an HIV-1 replication inhibitor.

Journal: RSC medicinal chemistry

Published: January 23, 2020

Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway Hypereosinophilia.

Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway Hypereosinophilia.

Journal: Journal of medicinal chemistry

Published: August 15, 2018

Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides.

Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides.

Journal: Journal of Alzheimer's disease : JAD

Published: March 06, 2018

Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening.

Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening.

Journal: Scientific reports

Published: September 26, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026